Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Bertero

Showing results (71-80 of 161) with videos related to

Pageof 17
Sort By:
Cancers|September 28, 2023
Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational ApproachesMario Levis, Alessio Gastino, Greta De Giorgi, et al.
Journal of Clinical Medicine|April 9, 2024
Understanding and Managing Pineal Parenchymal Tumors of Intermediate Differentiation: An In-Depth Exploration from Pathology to Adjuvant TherapiesAndrea Bianconi, Flavio Panico, Bruna Lo Zito, et al.
British Journal of Cancer|June 16, 2017
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS geneSara Mariani, Luca Bertero, Simona Osella-Abate, et al.
Current Issues in Molecular Biology|September 29, 2025
Tumor Immune Microenvironment and Checkpoint Inhibition in Clear Cell Ovarian Carcinoma: Bridging Tumor Biology and Clinical Application in ImmunotherapyFulvio Borella, Giulia Capella, Stefano Cosma, et al.
Virchows Archiv : an International Journal of Pathology|September 19, 2022
Overexpression of INSM1, NOTCH1, NEUROD1, and YAP1 genes is associated with adverse clinical outcome in pediatric neuroblastomaJasna Metovic, Francesca Napoli, Simona Osella-Abate, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 13, 2024
Multidisciplinary treatment of a rare rapidly progressive intracranial myxoid mesenchymal tumor of uncertain differentiation FET-CREB fusion-negativeFlavio Panico, Andrea Bianconi, Luca Bertero, et al.
Oncology Letters|December 15, 2018
ALK expression favorably impacts the prognosis of <i>NRAS</i>-mutated metastatic melanomasSimona Osella-Abate, Elisabetta Mereu, Elisa Pellegrino, et al.
Journal of Neuro-Oncology|December 3, 2013
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)Riccardo Soffietti, Elisa Trevisan, Luca Bertero, et al.
European Radiology|August 31, 2015
Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion mapsAntonella Castellano, Marina Donativi, Roberta Rudà, et al.
Endocrine-Related Cancer|February 2, 2018
The role of the AR/ER ratio in ER-positive breast cancer patientsNelson Rangel, Milena Rondon-Lagos, Laura Annaratone, et al.
Pageof 17

Showing results (71-80 of 161) with videos related to

Sort By:
Pageof 17
Cancers|September 28, 2023
Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational ApproachesMario Levis, Alessio Gastino, Greta De Giorgi, et al.
Journal of Clinical Medicine|April 9, 2024
Understanding and Managing Pineal Parenchymal Tumors of Intermediate Differentiation: An In-Depth Exploration from Pathology to Adjuvant TherapiesAndrea Bianconi, Flavio Panico, Bruna Lo Zito, et al.
British Journal of Cancer|June 16, 2017
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS geneSara Mariani, Luca Bertero, Simona Osella-Abate, et al.
Current Issues in Molecular Biology|September 29, 2025
Tumor Immune Microenvironment and Checkpoint Inhibition in Clear Cell Ovarian Carcinoma: Bridging Tumor Biology and Clinical Application in ImmunotherapyFulvio Borella, Giulia Capella, Stefano Cosma, et al.
Virchows Archiv : an International Journal of Pathology|September 19, 2022
Overexpression of INSM1, NOTCH1, NEUROD1, and YAP1 genes is associated with adverse clinical outcome in pediatric neuroblastomaJasna Metovic, Francesca Napoli, Simona Osella-Abate, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 13, 2024
Multidisciplinary treatment of a rare rapidly progressive intracranial myxoid mesenchymal tumor of uncertain differentiation FET-CREB fusion-negativeFlavio Panico, Andrea Bianconi, Luca Bertero, et al.
Oncology Letters|December 15, 2018
ALK expression favorably impacts the prognosis of <i>NRAS</i>-mutated metastatic melanomasSimona Osella-Abate, Elisabetta Mereu, Elisa Pellegrino, et al.
Journal of Neuro-Oncology|December 3, 2013
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)Riccardo Soffietti, Elisa Trevisan, Luca Bertero, et al.
European Radiology|August 31, 2015
Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion mapsAntonella Castellano, Marina Donativi, Roberta Rudà, et al.
Endocrine-Related Cancer|February 2, 2018
The role of the AR/ER ratio in ER-positive breast cancer patientsNelson Rangel, Milena Rondon-Lagos, Laura Annaratone, et al.
Pageof 17